Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MicroSectors FANG and Innovation 3X Leveraged ETN (FNGU) vs Tempus AI (TEM) Price & Performance

MicroSectors FANG and Innovation 3X Leveraged ETNTrade
Tempus AITrade

Price performance (Past 24H)

Key statistics

MicroSectors FANG and Innovation 3X Leveraged ETN vs Tempus AI — how do they compare? MicroSectors FANG and Innovation 3X Leveraged ETN trades at $28.83, while Tempus AI trades at $56.52 (market cap $10.28B). The key difference: MicroSectors FANG and Innovation 3X Leveraged ETN is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.

FNGUTEM
Sector
Leveraged / InverseBroad Market / Factor
52-Week High
$36.15$103.25
52-Week Low
$13.73$42.37
Market Cap
$10.28B
Enterprise Value
$10.96B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MicroSectors FANG and Innovation 3X Leveraged ETN

FNGU, a 3X leveraged ETN tracking the FANG+ Index, trades at $28.77, down 0.45% on the day. The technical picture is mixed, with moving averages signaling bullish momentum but oscillators and a high RSI indicating overbought conditions. Recent news highlights the extreme volatility and decay inherent to its leveraged structure, with one report noting a $10,000 position losing 16% in a single session in June 2026.

The outlook is dominated by the product's high-risk, tactical nature. The opportunity lies in capturing amplified gains during strong bullish trends in mega-cap tech. The primary risk is significant capital erosion during volatile or sideways markets due to daily resetting leverage and compounding costs, making it unsuitable for long-term holding.

Tempus AI

Tempus AI (TEM) trades at $55.62, down 5.1% over 24 hours, with a neutral technical signal and bullish moving average alignment. The company reported Q1 2026 revenue growth and an earnings beat, though it remains unprofitable with a net margin of -22.2%. Recent news highlights FDA clearances and partnerships, while analyst consensus is strongly positive with a $68.50 price target.

The outlook balances high-growth potential in AI-driven healthcare data against significant near-term losses. Investment opportunity lies in Tempus's unique data platform and expanding market reach, but risks include persistent cash burn and competitive pressures. Upside depends on achieving profitability and scaling high-margin segments.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About MicroSectors FANG and Innovation 3X Leveraged ETN

FNGU is a leveraged ETN that seeks to provide three times (3x) the daily performance of top tech and innovation stocks. It is intended for traders seeking magnified short-term returns.

Read more on FNGU

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM